Australia–New Zealand Expert Consensus Statement on Cardiac Amyloidosis (2024)

Regionally tailored recommendations on investigation, diagnosis, and management of cardiac amyloidosis, incorporating local service structures and therapy access.  Australia–New Zealand Expert Consensus Statement on Cardiac Amyloidosis (2024)   

ESC Working Group Position Statement: Diagnosis and Treatment of Cardiac Amyloidosis (2021) 

Outlines red flags for suspicion, diagnostic pathways, imaging, biopsy, and management of cardiac amyloidosis subtypes (ATTR-CM and AL-CM). ESC Working Group Position Statement: Diagnosis and Treatment of Cardiac Amyloidosis (2021)